CD213alpha2 Antikörper
-
- Target
- CD213alpha2
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Aufreinigung
- The antibody was purified by affinity chromatography.
- Klon
- SHM38
- Isotyp
- IgG1 kappa
-
anti-CD213alpha2 antibody
Reaktivität: Human FACS, IF Wirt: Maus Monoclonal 47 unconjugated
anti-CD213alpha2 antibody (PE)Reaktivität: Human ICFC, IHC Wirt: Maus Monoclonal SHM38 PE
anti-CD213alpha2 antibody (PE)Reaktivität: Human FACS Wirt: Maus Monoclonal 47 PE
anti-CD213alpha2 antibody (APC)Reaktivität: Human GS, WB Wirt: Maus Monoclonal SHM38 APC
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Target
- CD213alpha2
- Hintergrund
- CD213a2, also known as IL-13Rα2, is a type I transmembrane protein and member of the hematopoietin family. IL13Ra2 is the high affinity receptor for IL-13, but it possibly acts as a decoy receptor to antagonize IL-13Rα 1/IL-4Ra-mediated IL-13 biological functions. IL13Rα2 is expressed by fibroblasts, smooth muscle cells, keratinocytes and activated B cells. However, its presence on the cell surface is highly regulated. CD213a2 is also expressed in various types of cancer which makes it an attractive therapeutic target.
-
